Jefferies and JPMorgan Maintain Buy Ratings on Five Major Stocks

Jefferies set a price target of 215 pence for M&G, while Barclays separately maintained a Buy rating with a £3.61 target; M&G shares had closed at 357.40 pence the previous Monday.
Jefferies’ Hindustan Unilever analyst Vivek Maheshwari has a TipRanks record showing a 1.6% average return and a 46.88% success rate; his price target was INR2,450.
Jefferies analyst Koundinya Nimmagadda set a INR395 target for JSW Infrastructure, above the broader consensus target of INR384; TipRanks ranks him 10,050th among 12,444 analysts.
Jefferies set Geberit’s price target at CHF712, while the firm’s analyst Priyal Woolf had a TipRanks average return of -8.4% and a 24.74% success rate.
AstraZeneca received an additional Buy rating from Barclays analyst James Gordon CFA, alongside J.P. Morgan’s recommendation; J.P. Morgan set a £160 price target, and its analyst Richard Vosser is ranked 4,116th out of 12,444 analysts by TipRanks.
Major investment banks are backing five global stocks this week. Jefferies maintained Buy ratings on M&G, Hindustan Unilever, JSW Infrastructure, and Geberit, while JPMorgan reiterated its Buy call on AstraZeneca. The stocks span insurance, consumer goods, infrastructure, and pharmaceuticals across multiple markets.
Mixed earnings results accompany these optimistic calls. M&G posted £11.18 billion in revenue but swung to a £170 million loss from a £243 million profit year earlier. Hindustan Unilever's revenue hit INR171.84 billion while profit fell to INR26.73 billion. JSW Infrastructure's revenue grew to INR14.45 billion, though profit dropped to INR3.47 billion.
M&G's latest results show financial strain. Revenue climbed to £11.18 billion, but the company flipped to a £170 million loss. Jefferies set a 215 pence price target, while Barclays maintained its own Buy rating with a £3.61 target. M&G shares closed at 357.40 pence the previous Monday, leaving room between current and target prices.
Jefferies analyst Vivek Maheshwari maintains a Buy rating on Hindustan Unilever with an INR2,450 price target. The broader market consensus stands at Moderate Buy with an average target of INR2,437.50. Maheshwari has a strong TipRanks record: 46.88% success rate and 1.6% average return, according to TipRanks data.
Revenue for the consumer goods giant reached INR171.84 billion in its latest quarter. Profit declined to INR26.73 billion, signaling margin pressure despite strong top-line growth. Most analysts remain bullish on the company's long-term prospects.
Jefferies analyst Koundinya Nimmagadda set an INR395 price target for JSW Infrastructure, above the broader consensus of INR384. The infrastructure play grew revenue to INR14.45 billion in the latest quarter. Nimmagadda ranks 10,050th among 12,444 analysts tracked by TipRanks, placing him in the middle of the analyst pack.
JPMorgan and Barclays both maintain Buy ratings on AstraZeneca, with JPMorgan setting a £160 price target. RBC Capital also backs the stock with an "Outperform" rating and £145 target. However, Deutsche Bank struck a contrasting Sell rating, showing real disagreement among top research shops.
AstraZeneca posted modest revenue growth with nearly flat profit at £2.49 billion. MarketBeat reports consensus as "Moderate Buy" from six analysts, with one Sell and five Buy ratings. JPMorgan's Richard Vosser ranks 4,116th out of 12,444 analysts on TipRanks, a top-quartile position in the research community.
Jefferies maintains a Buy rating on Swiss industrial group Geberit with a CHF712 price target. Goldman Sachs also backs the stock, providing additional support. Citi takes a contrasting Hold stance, showing typical divergence on quality industrial plays in mature markets.
Geberit reported higher revenue and profit year over year, demonstrating solid operational momentum. Jefferies analyst Priyal Woolf shows mixed historical performance on TipRanks: -8.4% average return but a 24.74% success rate. The divergence suggests Woolf picks winners and losers but with timing challenges.
Publishers
15
Articles
8
Reach
23